<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02838914</url>
  </required_header>
  <id_info>
    <org_study_id>XH-16-006</org_study_id>
    <nct_id>NCT02838914</nct_id>
  </id_info>
  <brief_title>Assessment of Reconstruction and Inverse Reconstruction in Right Atrium by Multimodal Echocardiographic Techniques</brief_title>
  <official_title>Assessment of Reconstruction and Inverse Reconstruction in Right Atrium by by Multimodal Echocardiographic Techniques for Atrial Fibrillation Patients Before and After Radiofrequency Ablation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to assess the reconstruction and inverse reconstruction in right
      atrium by speckle tracking echocardiography combined with real-time three dimensional
      echocardiography for atrial fibrillation patients before and after radiofrequency ablation
      (RFCA)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence of atrial fibrillation (AF) has increased in recent years. The construction
      and function of right atrium haven't shown clearly before and after radiofrequency ablation
      (RFCA).The purpose of the study is to investigate whether RFCA can lead to inverse
      reconstruction of right atrium for atrial fibrillation patients, which diagnosing by speckle
      tracking echocardiography combined with real-time three dimensional echocardiography. All
      patients will be followed up for 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Remodeling in right atrium measured by speckle tracking echocardiography combined with real-time three dimensional echocardiography in AF patients</measure>
    <time_frame>In one week before RFCA</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Remodeling in right atrium measured by speckle tracking echocardiography combined with real-time three dimensional echocardiography in AF patients</measure>
    <time_frame>In one week after RFCA</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inverse reconstruction in right atrium measured by speckle tracking echocardiography combined with real-time three dimensional echocardiography in AF patients</measure>
    <time_frame>At three months after RFCA</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inverse reconstruction in right atrium measured by speckle tracking echocardiography combined with real-time three dimensional echocardiography in AF patients</measure>
    <time_frame>At six months after RFCA</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse event that is related to RFCA, such as the incidence of cardiac tamponade (%) was obtained by echocardiography</measure>
    <time_frame>In one week after RFCA</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Adverse events that are related to RFCA, such as the incidence of pulmonary vein stenosis(%) and embolism(%) were obtained by CT</measure>
    <time_frame>At six months after RFCA</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>patients with AF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Before radiofrequency ablation (RFCA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Assigned Comparisons</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After radiofrequency ablation (RFCA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>radiofrequency ablation (RFCA)</intervention_name>
    <description>Patients undergo radiofrequency ablation (RFCA)</description>
    <arm_group_label>patients with AF</arm_group_label>
    <arm_group_label>Assigned Comparisons</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. With a history of paroxysmal Af (PAF) and PAF record within 6 months prior to
             ablation, confirming at least one of the following findings: AF lasting for â‰¥30 s
             recorded in Holter or 12-lead ECG.

          2. No response to more than one antiarrhythmic drug, or unwilling to receive longterm
             drug treatment.

          3. Can provide informed consent form expressing willingness to participate in the study
             and comply with follow-up tests and evaluation procedures.

          4. Aged 18-80 years.

        Exclusion Criteria:

          1. With acute diseases, such as acute phase after myocardial infarction (within 3
             months), within 3 months after acute heart failure or new cerebral infarction;

          2. In the list of heart transplantation;

          3. Expected survival less than 1 year;

          4. With other hemorrhagic diseases and anticoagulant therapy is not allowed;

          5. Thrombosis in left atrium;

          6. Heart failure, New York Heart Association(NYHA) III/IV or eject fraction(EF)&lt;40%;

          7. Patients with uncontrolled cancer;

          8. Significant hepatic or renal impairment (and/or alanine transaminase(ALT) or Aspartate
             transaminase(AST) &gt;2 times upper limit of normal, creatinine clearance rate(CCr)&lt;50%);

          9. Previous catheter radiofrequency ablation for AF or cardiac surgery;

         10. Pregnant and lactating women, women who plan to become pregnant, or women of child
             bearing age not using reliable contraceptive measures.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kun Sun, M.D.;Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ultrasound, Xinhua Hospital, Shanghai Jiaotong University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kun Sun, M.D.;Ph.D.</last_name>
    <phone>13651696395</phone>
    <email>sunkunxh@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yi Yu, M.D.</last_name>
    <phone>13817308128</phone>
    <email>yuyi20122012@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xinhua Hospital,Shanghai Jiao Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <zip>200092</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kun Sun, M.D.;Ph.D</last_name>
      <phone>13651696395</phone>
      <email>Sunkunxh@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Yi Yu, M.D.</last_name>
      <phone>13817308128</phone>
      <email>yuyi20122012@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Thihalolipavan S, Morin DP. Atrial fibrillation and congestive heart failure. Heart Fail Clin. 2014 Apr;10(2):305-18. doi: 10.1016/j.hfc.2013.12.005. Epub 2014 Feb 4. Review.</citation>
    <PMID>24656107</PMID>
  </results_reference>
  <results_reference>
    <citation>Extramiana F, Maison-Blanche P. Stroke and atrial fibrillation: where to go from here? Stroke. 2015 Mar;46(3):605-7. doi: 10.1161/STROKEAHA.114.007809. Epub 2015 Jan 29.</citation>
    <PMID>25634002</PMID>
  </results_reference>
  <results_reference>
    <citation>January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76. doi: 10.1016/j.jacc.2014.03.022. Epub 2014 Mar 28. Review. Erratum in: J Am Coll Cardiol. 2014 Dec 2;64(21):2305-7.</citation>
    <PMID>24685669</PMID>
  </results_reference>
  <results_reference>
    <citation>Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH; ESC Committee for Practice Guidelines. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010 Oct;12(10):1360-420. doi: 10.1093/europace/euq350. Erratum in: Europace. 2011 Jul;13(7):1058. Dosage error in article text.</citation>
    <PMID>20876603</PMID>
  </results_reference>
  <results_reference>
    <citation>Rondano E, Dell'Era G, De Luca G, Piccinino C, Bellomo G, Marino PN. Left atrial asynchrony is a major predictor of 1-year recurrence of atrial fibrillation after electrical cardioversion. J Cardiovasc Med (Hagerstown). 2010 Jul;11(7):499-506. doi: 10.2459/JCM.0b013e32833757b5.</citation>
    <PMID>20445461</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang Z, Tan H, Zhong M, Jiang G, Zhang Y, Zhang W. Strain rate imaging for noninvasive functional quantification of the left atrium in hypertensive patients with paroxysmal atrial fibrillation. Cardiology. 2008;109(1):15-24. Epub 2007 Jul 10.</citation>
    <PMID>17627105</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee YS, Hyun DW, Jung BC, Cho YK, Lee SH, Shin DG, Park HS, Han SW, Kim YN; KTK Cardiac Electrophysiology Working Group. Left atrial volume index as a predictor for occurrence of atrial fibrillation after ablation of typical atrial flutter. J Cardiol. 2010 Nov;56(3):348-53. doi: 10.1016/j.jjcc.2010.07.006.</citation>
    <PMID>20889311</PMID>
  </results_reference>
  <results_reference>
    <citation>MÃ¼ller H, Reverdin S, Burri H, Shah D, Lerch R. Measurement of left and right atrial volume in patients undergoing ablation for atrial arrhythmias: comparison of a manual versus semiautomatic algorithm of real time 3D echocardiography. Echocardiography. 2014 Apr;31(4):499-507. doi: 10.1111/echo.12391. Epub 2013 Oct 15.</citation>
    <PMID>24128369</PMID>
  </results_reference>
  <results_reference>
    <citation>Peluso D, Badano LP, Muraru D, Dal Bianco L, Cucchini U, Kocabay G, KovÃ cs A, Casablanca S, Iliceto S. Right atrial size and function assessed with three-dimensional and speckle-tracking echocardiography in 200 healthy volunteers. Eur Heart J Cardiovasc Imaging. 2013 Nov;14(11):1106-14. doi: 10.1093/ehjci/jet024. Epub 2013 Feb 19.</citation>
    <PMID>23423966</PMID>
  </results_reference>
  <results_reference>
    <citation>Marwick TH, Leano RL, Brown J, Sun JP, Hoffmann R, Lysyansky P, Becker M, Thomas JD. Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range. JACC Cardiovasc Imaging. 2009 Jan;2(1):80-4. doi: 10.1016/j.jcmg.2007.12.007.</citation>
    <PMID>19356538</PMID>
  </results_reference>
  <results_reference>
    <citation>Reant P, Labrousse L, Lafitte S, Bordachar P, Pillois X, Tariosse L, Bonoron-Adele S, Padois P, Deville C, Roudaut R, Dos Santos P. Experimental validation of circumferential, longitudinal, and radial 2-dimensional strain during dobutamine stress echocardiography in ischemic conditions. J Am Coll Cardiol. 2008 Jan 15;51(2):149-57. doi: 10.1016/j.jacc.2007.07.088.</citation>
    <PMID>18191740</PMID>
  </results_reference>
  <results_reference>
    <citation>Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M, Marwick T, Nagueh SF, Sengupta PP, Sicari R, Smiseth OA, Smulevitz B, Takeuchi M, Thomas JD, Vannan M, Voigt JU, Zamorano JL. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr. 2011 Mar;12(3):167-205. doi: 10.1093/ejechocard/jer021. Review.</citation>
    <PMID>21385887</PMID>
  </results_reference>
  <results_reference>
    <citation>Mirza M, Caracciolo G, Khan U, Mori N, Saha SK, Srivathsan K, Altemose G, Scott L, Sengupta P, Jahangir A. Left atrial reservoir function predicts atrial fibrillation recurrence after catheter ablation: a two-dimensional speckle strain study. J Interv Card Electrophysiol. 2011 Sep;31(3):197-206. doi: 10.1007/s10840-011-9560-6. Epub 2011 Mar 22.</citation>
    <PMID>21424845</PMID>
  </results_reference>
  <results_reference>
    <citation>Puwanant S, Park M, PopoviÄ‡ ZB, Tang WH, Farha S, George D, Sharp J, Puntawangkoon J, Loyd JE, Erzurum SC, Thomas JD. Ventricular geometry, strain, and rotational mechanics in pulmonary hypertension. Circulation. 2010 Jan 19;121(2):259-66. doi: 10.1161/CIRCULATIONAHA.108.844340. Epub 2010 Jan 4.</citation>
    <PMID>20048214</PMID>
  </results_reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2016</study_first_submitted>
  <study_first_submitted_qc>July 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2016</study_first_posted>
  <last_update_submitted>May 17, 2018</last_update_submitted>
  <last_update_submitted_qc>May 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Yi Yu</investigator_full_name>
    <investigator_title>vice professor</investigator_title>
  </responsible_party>
  <keyword>Right atrium</keyword>
  <keyword>Echocardiography</keyword>
  <keyword>Remodeling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

